Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.10383309 |
2 | NIK/NF-kappaB signaling (GO:0038061) | 4.31803326 |
3 | thymic T cell selection (GO:0045061) | 4.18871153 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.15945541 |
5 | response to muramyl dipeptide (GO:0032495) | 4.06144727 |
6 | positive thymic T cell selection (GO:0045059) | 3.92132670 |
7 | negative thymic T cell selection (GO:0045060) | 3.85178570 |
8 | mannose metabolic process (GO:0006013) | 3.81054749 |
9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.64439572 |
10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.63701339 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61803500 |
12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.52238490 |
13 | negative T cell selection (GO:0043383) | 3.50914743 |
14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45464488 |
15 | modulation by symbiont of host defense response (GO:0052031) | 3.45464488 |
16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45464488 |
17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45464488 |
18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45464488 |
19 | modulation by symbiont of host immune response (GO:0052553) | 3.45464488 |
20 | tolerance induction (GO:0002507) | 3.42921992 |
21 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.41705076 |
22 | T cell selection (GO:0045058) | 3.41555275 |
23 | germinal center formation (GO:0002467) | 3.38343839 |
24 | B cell receptor signaling pathway (GO:0050853) | 3.33087404 |
25 | regulation of histone H3-K27 methylation (GO:0061085) | 3.29829776 |
26 | apoptotic process involved in morphogenesis (GO:0060561) | 3.27316041 |
27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24440074 |
28 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.23906687 |
29 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.19936313 |
30 | myeloid dendritic cell differentiation (GO:0043011) | 3.19887267 |
31 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.19420106 |
32 | response to laminar fluid shear stress (GO:0034616) | 3.18355998 |
33 | response to peptidoglycan (GO:0032494) | 3.16409981 |
34 | modulation by symbiont of host cellular process (GO:0044068) | 3.13104525 |
35 | B cell homeostasis (GO:0001782) | 3.12907187 |
36 | negative regulation of cell killing (GO:0031342) | 3.10410878 |
37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10410878 |
38 | T cell migration (GO:0072678) | 3.09681808 |
39 | modulation by virus of host process (GO:0019054) | 3.06593849 |
40 | activation of MAPKKK activity (GO:0000185) | 3.06494009 |
41 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.06156653 |
42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04637395 |
43 | immunoglobulin mediated immune response (GO:0016064) | 3.03260052 |
44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96107630 |
45 | histone H3-K36 demethylation (GO:0070544) | 2.95694693 |
46 | activation of Rac GTPase activity (GO:0032863) | 2.94712827 |
47 | positive T cell selection (GO:0043368) | 2.94191502 |
48 | protein localization to endosome (GO:0036010) | 2.92348963 |
49 | detection of bacterium (GO:0016045) | 2.87609805 |
50 | positive regulation of histone deacetylation (GO:0031065) | 2.87340354 |
51 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.85099049 |
52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84790417 |
53 | myeloid dendritic cell activation (GO:0001773) | 2.84421557 |
54 | cellular response to interleukin-4 (GO:0071353) | 2.80747044 |
55 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.76101859 |
56 | pinocytosis (GO:0006907) | 2.74746661 |
57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74122833 |
58 | positive regulation of B cell differentiation (GO:0045579) | 2.73016453 |
59 | negative regulation of viral release from host cell (GO:1902187) | 2.72326293 |
60 | detection of other organism (GO:0098543) | 2.67813564 |
61 | embryonic process involved in female pregnancy (GO:0060136) | 2.65073265 |
62 | regulation of chromatin binding (GO:0035561) | 2.63565275 |
63 | response to interleukin-15 (GO:0070672) | 2.63145728 |
64 | response to type I interferon (GO:0034340) | 2.58698489 |
65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58577423 |
66 | macrophage activation involved in immune response (GO:0002281) | 2.57975202 |
67 | cellular response to type I interferon (GO:0071357) | 2.57805005 |
68 | type I interferon signaling pathway (GO:0060337) | 2.57805005 |
69 | T cell lineage commitment (GO:0002360) | 2.57392886 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57258150 |
71 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56946550 |
72 | regulation of monocyte differentiation (GO:0045655) | 2.49695145 |
73 | negative regulation of phagocytosis (GO:0050765) | 2.48794000 |
74 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.48181052 |
75 | response to interleukin-4 (GO:0070670) | 2.47564305 |
76 | COPI coating of Golgi vesicle (GO:0048205) | 2.47343992 |
77 | Golgi transport vesicle coating (GO:0048200) | 2.47343992 |
78 | lymphocyte homeostasis (GO:0002260) | 2.47130237 |
79 | leukocyte aggregation (GO:0070486) | 2.46696236 |
80 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.44969804 |
81 | focal adhesion assembly (GO:0048041) | 2.44071433 |
82 | cell-substrate adherens junction assembly (GO:0007045) | 2.44071433 |
83 | megakaryocyte development (GO:0035855) | 2.44027685 |
84 | signal complex assembly (GO:0007172) | 2.43027574 |
85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42836136 |
86 | activation of JUN kinase activity (GO:0007257) | 2.42641992 |
87 | proline biosynthetic process (GO:0006561) | 2.42597486 |
88 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.41096645 |
89 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.40056611 |
90 | T-helper 1 type immune response (GO:0042088) | 2.39734301 |
91 | T cell costimulation (GO:0031295) | 2.37796633 |
92 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37172540 |
93 | regulation of B cell differentiation (GO:0045577) | 2.37170990 |
94 | negative regulation of cell size (GO:0045792) | 2.36933228 |
95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.35971838 |
96 | adherens junction assembly (GO:0034333) | 2.35279928 |
97 | cellular response to virus (GO:0098586) | 2.35071864 |
98 | positive regulation of protein deacetylation (GO:0090312) | 2.34503637 |
99 | B cell mediated immunity (GO:0019724) | 2.33987863 |
100 | regulation of extracellular matrix disassembly (GO:0010715) | 2.33523305 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MYC_22102868_ChIP-Seq_BL_Human | 3.94337120 |
2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.39799620 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.66767115 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59253395 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58400501 |
6 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.54926476 |
7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49383872 |
8 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.45638088 |
9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.44749143 |
10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38931933 |
11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.36347600 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34582801 |
13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.19786286 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.19670213 |
15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06714892 |
16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01193809 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98088112 |
18 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.97899075 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90810816 |
20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88421751 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.86998184 |
22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86236172 |
23 | MAF_26560356_Chip-Seq_TH2_Human | 1.81022771 |
24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80482496 |
25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79948136 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77043024 |
27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67168640 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64841747 |
29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61426272 |
30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60903274 |
31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60828744 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56052043 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53119128 |
34 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51985692 |
35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49578798 |
36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47194727 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46571418 |
38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46307257 |
39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42348919 |
40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41240331 |
41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40307997 |
42 | P68_20966046_ChIP-Seq_HELA_Human | 1.40069720 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40010452 |
44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39275657 |
45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38405519 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.37148568 |
47 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.36991165 |
48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33978217 |
49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32910002 |
50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31544428 |
51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.31049754 |
52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30918195 |
53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30862564 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30276281 |
55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29984654 |
56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29960176 |
57 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28092149 |
58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26506537 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25751107 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25005895 |
61 | MYB_26560356_Chip-Seq_TH2_Human | 1.23163668 |
62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23154765 |
63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23014705 |
64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22225755 |
65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20989645 |
66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20290663 |
67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18531928 |
68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17652848 |
69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16355117 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15741888 |
71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15209084 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14957086 |
73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14956105 |
74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12269088 |
75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11996467 |
76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11893020 |
77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11481744 |
78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10760781 |
79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10582880 |
80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10346838 |
81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09886772 |
82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09774484 |
83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09258194 |
84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09162595 |
85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09109626 |
86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.09065593 |
87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07576099 |
88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06475507 |
89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06471200 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04222558 |
91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02702915 |
92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02627129 |
93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01278278 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00061148 |
95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99814065 |
96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99078112 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97270015 |
98 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96690597 |
99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95820348 |
100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95792905 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 3.29058495 |
2 | MP0003763_abnormal_thymus_physiology | 3.01771567 |
3 | MP0000685_abnormal_immune_system | 2.92078375 |
4 | MP0003303_peritoneal_inflammation | 2.66816203 |
5 | MP0005058_abnormal_lysosome_morphology | 2.65626128 |
6 | MP0005451_abnormal_body_composition | 2.59278796 |
7 | MP0005671_abnormal_response_to | 2.50499455 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.43534246 |
9 | MP0003172_abnormal_lysosome_physiology | 2.42763757 |
10 | MP0003300_gastrointestinal_ulcer | 2.40892823 |
11 | MP0001835_abnormal_antigen_presentation | 2.39913606 |
12 | MP0001790_abnormal_immune_system | 2.39645227 |
13 | MP0005387_immune_system_phenotype | 2.39645227 |
14 | MP0005000_abnormal_immune_tolerance | 2.33665261 |
15 | MP0009333_abnormal_splenocyte_physiolog | 2.32738726 |
16 | MP0001800_abnormal_humoral_immune | 2.31466693 |
17 | MP0005076_abnormal_cell_differentiation | 2.29387125 |
18 | MP0002396_abnormal_hematopoietic_system | 2.12198275 |
19 | MP0004947_skin_inflammation | 2.03914835 |
20 | MP0009278_abnormal_bone_marrow | 2.02127571 |
21 | MP0002452_abnormal_antigen_presenting | 1.93841489 |
22 | MP0002398_abnormal_bone_marrow | 1.92380107 |
23 | MP0002723_abnormal_immune_serum | 1.92080424 |
24 | MP0001873_stomach_inflammation | 1.89514056 |
25 | MP0002420_abnormal_adaptive_immunity | 1.88470843 |
26 | MP0008260_abnormal_autophagy | 1.88465846 |
27 | MP0001819_abnormal_immune_cell | 1.85894387 |
28 | MP0005025_abnormal_response_to | 1.82682380 |
29 | MP0009840_abnormal_foam_cell | 1.78032243 |
30 | MP0002419_abnormal_innate_immunity | 1.77615456 |
31 | MP0005310_abnormal_salivary_gland | 1.73577930 |
32 | MP0001348_abnormal_lacrimal_gland | 1.71003051 |
33 | MP0003453_abnormal_keratinocyte_physiol | 1.70655889 |
34 | MP0002166_altered_tumor_susceptibility | 1.70216264 |
35 | MP0000703_abnormal_thymus_morphology | 1.66782463 |
36 | MP0000716_abnormal_immune_system | 1.66253417 |
37 | MP0001849_ear_inflammation | 1.61154281 |
38 | MP0004808_abnormal_hematopoietic_stem | 1.60942807 |
39 | MP0002877_abnormal_melanocyte_morpholog | 1.57184610 |
40 | MP0004510_myositis | 1.56609593 |
41 | MP0010234_abnormal_vibrissa_follicle | 1.56545388 |
42 | MP0004185_abnormal_adipocyte_glucose | 1.54754530 |
43 | MP0003091_abnormal_cell_migration | 1.53643672 |
44 | MP0002405_respiratory_system_inflammati | 1.53196914 |
45 | MP0002722_abnormal_immune_system | 1.52074975 |
46 | MP0000858_altered_metastatic_potential | 1.50747888 |
47 | MP0010155_abnormal_intestine_physiology | 1.49523840 |
48 | MP0002429_abnormal_blood_cell | 1.49171792 |
49 | MP0001853_heart_inflammation | 1.48531634 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.44589335 |
51 | MP0000689_abnormal_spleen_morphology | 1.43694742 |
52 | MP0005464_abnormal_platelet_physiology | 1.41867682 |
53 | MP0002148_abnormal_hypersensitivity_rea | 1.38079549 |
54 | MP0004381_abnormal_hair_follicle | 1.36950198 |
55 | MP0002998_abnormal_bone_remodeling | 1.24874702 |
56 | MP0003566_abnormal_cell_adhesion | 1.22407223 |
57 | MP0009785_altered_susceptibility_to | 1.18983060 |
58 | MP0002138_abnormal_hepatobiliary_system | 1.17890804 |
59 | MP0001845_abnormal_inflammatory_respons | 1.17552698 |
60 | MP0000490_abnormal_crypts_of | 1.17380277 |
61 | MP0002006_tumorigenesis | 1.17351352 |
62 | MP0001545_abnormal_hematopoietic_system | 1.17011418 |
63 | MP0005397_hematopoietic_system_phenotyp | 1.17011418 |
64 | MP0001533_abnormal_skeleton_physiology | 1.12876704 |
65 | MP0003111_abnormal_nucleus_morphology | 1.02524618 |
66 | MP0005666_abnormal_adipose_tissue | 1.02469728 |
67 | MP0008961_abnormal_basal_metabolism | 1.02037392 |
68 | MP0002009_preneoplasia | 1.01877695 |
69 | MP0002254_reproductive_system_inflammat | 1.00411748 |
70 | MP0005621_abnormal_cell_physiology | 0.97485434 |
71 | MP0001730_embryonic_growth_arrest | 0.97059019 |
72 | MP0003183_abnormal_peptide_metabolism | 0.96208888 |
73 | MP0005375_adipose_tissue_phenotype | 0.95131265 |
74 | MP0002933_joint_inflammation | 0.91947616 |
75 | MP0002089_abnormal_postnatal_growth/wei | 0.91557891 |
76 | MP0002796_impaired_skin_barrier | 0.90095542 |
77 | MP0005360_urolithiasis | 0.89947894 |
78 | MP0002019_abnormal_tumor_incidence | 0.88156816 |
79 | MP0008469_abnormal_protein_level | 0.87774868 |
80 | MP0000003_abnormal_adipose_tissue | 0.87751109 |
81 | MP0000350_abnormal_cell_proliferation | 0.87722736 |
82 | MP0005501_abnormal_skin_physiology | 0.84530210 |
83 | MP0001851_eye_inflammation | 0.84474259 |
84 | MP0000604_amyloidosis | 0.82211678 |
85 | MP0000313_abnormal_cell_death | 0.79531377 |
86 | MP0003866_abnormal_defecation | 0.78101199 |
87 | MP0009931_abnormal_skin_appearance | 0.77818588 |
88 | MP0001216_abnormal_epidermal_layer | 0.75486343 |
89 | MP0001727_abnormal_embryo_implantation | 0.75354095 |
90 | MP0003077_abnormal_cell_cycle | 0.75127543 |
91 | MP0000678_abnormal_parathyroid_gland | 0.73848277 |
92 | MP0006082_CNS_inflammation | 0.72214127 |
93 | MP0000733_abnormal_muscle_development | 0.71847555 |
94 | MP0003656_abnormal_erythrocyte_physiolo | 0.71497701 |
95 | MP0003448_altered_tumor_morphology | 0.70672698 |
96 | MP0010352_gastrointestinal_tract_polyps | 0.67911951 |
97 | MP0005384_cellular_phenotype | 0.67207191 |
98 | MP0002970_abnormal_white_adipose | 0.66398421 |
99 | MP0000609_abnormal_liver_physiology | 0.65972171 |
100 | MP0003075_altered_response_to | 0.65642888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Gastrointestinal stroma tumor (HP:0100723) | 3.76764837 |
2 | Eczematoid dermatitis (HP:0000976) | 3.65989868 |
3 | Cellulitis (HP:0100658) | 3.14042587 |
4 | Broad face (HP:0000283) | 3.10940153 |
5 | Hyperacusis (HP:0010780) | 3.06122209 |
6 | Recurrent viral infections (HP:0004429) | 2.94501956 |
7 | Agammaglobulinemia (HP:0004432) | 2.93291988 |
8 | Increased IgE level (HP:0003212) | 2.92783672 |
9 | Colitis (HP:0002583) | 2.91111610 |
10 | Abnormality of macrophages (HP:0004311) | 2.83515616 |
11 | Emphysema (HP:0002097) | 2.68046291 |
12 | Meningitis (HP:0001287) | 2.65855980 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 2.61748856 |
14 | Gastrointestinal inflammation (HP:0004386) | 2.59532733 |
15 | Abnormality of the fingertips (HP:0001211) | 2.50946702 |
16 | Obstructive sleep apnea (HP:0002870) | 2.50737719 |
17 | Panhypogammaglobulinemia (HP:0003139) | 2.46772802 |
18 | Recurrent fungal infections (HP:0002841) | 2.41523425 |
19 | Distal lower limb amyotrophy (HP:0008944) | 2.38285999 |
20 | Lymphopenia (HP:0001888) | 2.36053077 |
21 | Thin bony cortex (HP:0002753) | 2.35623201 |
22 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33511195 |
23 | Recurrent bacterial skin infections (HP:0005406) | 2.29789186 |
24 | Recurrent abscess formation (HP:0002722) | 2.29363768 |
25 | Pustule (HP:0200039) | 2.29359048 |
26 | Inflammation of the large intestine (HP:0002037) | 2.29340500 |
27 | Long palpebral fissure (HP:0000637) | 2.27969755 |
28 | Vasculitis (HP:0002633) | 2.26894855 |
29 | Dysostosis multiplex (HP:0000943) | 2.26300549 |
30 | Papilloma (HP:0012740) | 2.22768453 |
31 | Verrucae (HP:0200043) | 2.22768453 |
32 | Restrictive lung disease (HP:0002091) | 2.21586153 |
33 | Hemorrhage of the eye (HP:0011885) | 2.21319707 |
34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20337428 |
35 | Abnormality of the thoracic spine (HP:0100711) | 2.18423613 |
36 | Fatigue (HP:0012378) | 2.16497373 |
37 | Viral hepatitis (HP:0006562) | 2.14082982 |
38 | Recurrent sinusitis (HP:0011108) | 2.13185069 |
39 | IgA deficiency (HP:0002720) | 2.10869306 |
40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.09122440 |
41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08833184 |
42 | Obstructive lung disease (HP:0006536) | 2.08766841 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08766841 |
44 | Cerebral aneurysm (HP:0004944) | 2.07194333 |
45 | Increased cerebral lipofuscin (HP:0011813) | 2.07186805 |
46 | Thoracic kyphosis (HP:0002942) | 2.07079051 |
47 | Hypertensive crisis (HP:0100735) | 2.05180902 |
48 | Easy fatigability (HP:0003388) | 2.04717805 |
49 | Disproportionate tall stature (HP:0001519) | 2.01295697 |
50 | Osteomyelitis (HP:0002754) | 1.96475795 |
51 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93071664 |
52 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93071664 |
53 | Peripheral hypomyelination (HP:0007182) | 1.91718105 |
54 | Achilles tendon contracture (HP:0001771) | 1.89358363 |
55 | Polygenic inheritance (HP:0010982) | 1.88901084 |
56 | Slow saccadic eye movements (HP:0000514) | 1.88146719 |
57 | Basal cell carcinoma (HP:0002671) | 1.88090283 |
58 | Loss of speech (HP:0002371) | 1.87957878 |
59 | Urticaria (HP:0001025) | 1.87000820 |
60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86190203 |
61 | J-shaped sella turcica (HP:0002680) | 1.85760952 |
62 | Spontaneous hematomas (HP:0007420) | 1.82958410 |
63 | Premature loss of primary teeth (HP:0006323) | 1.82765837 |
64 | Cholecystitis (HP:0001082) | 1.82497771 |
65 | Abnormal gallbladder physiology (HP:0012438) | 1.82497771 |
66 | Deep palmar crease (HP:0006191) | 1.82251301 |
67 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80473354 |
68 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80473354 |
69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80473354 |
70 | Hepatitis (HP:0012115) | 1.80125526 |
71 | Urethral obstruction (HP:0000796) | 1.78781415 |
72 | Neuronal loss in central nervous system (HP:0002529) | 1.77809716 |
73 | IgM deficiency (HP:0002850) | 1.77659797 |
74 | Recurrent skin infections (HP:0001581) | 1.77164019 |
75 | Flat acetabular roof (HP:0003180) | 1.76079034 |
76 | Increased connective tissue (HP:0009025) | 1.74445254 |
77 | Abnormality of T cell physiology (HP:0011840) | 1.73909972 |
78 | Gingivitis (HP:0000230) | 1.73537323 |
79 | Seborrheic dermatitis (HP:0001051) | 1.73442416 |
80 | Mucopolysacchariduria (HP:0008155) | 1.72051956 |
81 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72051956 |
82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71868372 |
83 | Purpura (HP:0000979) | 1.71477094 |
84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71237220 |
85 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71237220 |
86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71237220 |
87 | Squamous cell carcinoma (HP:0002860) | 1.68818329 |
88 | Upper limb amyotrophy (HP:0009129) | 1.68595426 |
89 | Distal upper limb amyotrophy (HP:0007149) | 1.68595426 |
90 | Stridor (HP:0010307) | 1.68153842 |
91 | Premature skin wrinkling (HP:0100678) | 1.66725705 |
92 | Teleangiectasia of the skin (HP:0100585) | 1.65892259 |
93 | Petechiae (HP:0000967) | 1.65768896 |
94 | Abnormality of the Achilles tendon (HP:0005109) | 1.65532706 |
95 | Progressive external ophthalmoplegia (HP:0000590) | 1.65418329 |
96 | Dislocated radial head (HP:0003083) | 1.64891345 |
97 | Ulnar bowing (HP:0003031) | 1.64256996 |
98 | Acrocyanosis (HP:0001063) | 1.63665065 |
99 | Recurrent bronchitis (HP:0002837) | 1.62738673 |
100 | Progressive muscle weakness (HP:0003323) | 1.62702535 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 4.28379759 |
2 | SMG1 | 4.01811002 |
3 | TRIB3 | 3.94059351 |
4 | MAP4K1 | 3.16907959 |
5 | SIK1 | 3.16696261 |
6 | EEF2K | 2.78386296 |
7 | CDK12 | 2.78337709 |
8 | ERN1 | 2.63974515 |
9 | ICK | 2.53411356 |
10 | IRAK3 | 2.32627727 |
11 | MAP3K10 | 2.30303977 |
12 | RIPK4 | 2.17401848 |
13 | MAP3K14 | 2.13683153 |
14 | FGFR4 | 1.92422775 |
15 | MAP3K13 | 1.87696525 |
16 | SIK3 | 1.80015924 |
17 | SIK2 | 1.78581863 |
18 | IRAK4 | 1.70237362 |
19 | NME2 | 1.62759077 |
20 | PKN2 | 1.56896789 |
21 | MAP2K3 | 1.51262422 |
22 | TAOK2 | 1.38605274 |
23 | TBK1 | 1.37831675 |
24 | TNK2 | 1.29570699 |
25 | TYK2 | 1.23079019 |
26 | MARK2 | 1.05981085 |
27 | JAK3 | 1.05069634 |
28 | PASK | 1.05019128 |
29 | TAOK1 | 1.02983644 |
30 | CDC42BPA | 1.02540074 |
31 | TTN | 1.01620695 |
32 | MAP3K11 | 1.00204694 |
33 | CDK4 | 0.98051460 |
34 | BTK | 0.97984066 |
35 | PRKD2 | 0.96504062 |
36 | CSF1R | 0.94580035 |
37 | BRD4 | 0.94544060 |
38 | MTOR | 0.94181486 |
39 | MAPK11 | 0.93047128 |
40 | ZAP70 | 0.90856348 |
41 | EPHB1 | 0.88076509 |
42 | HIPK2 | 0.87778684 |
43 | IKBKB | 0.86868187 |
44 | IRAK2 | 0.85546219 |
45 | IKBKE | 0.85416594 |
46 | JAK1 | 0.83451645 |
47 | MAP3K1 | 0.81412266 |
48 | BLK | 0.80270908 |
49 | MAP3K3 | 0.77964192 |
50 | CHUK | 0.77843237 |
51 | CSK | 0.77460223 |
52 | FGFR3 | 0.74789274 |
53 | MAP3K8 | 0.69082434 |
54 | CDK9 | 0.68649017 |
55 | PIM2 | 0.68597992 |
56 | HCK | 0.68302979 |
57 | PTK6 | 0.68104868 |
58 | PDGFRA | 0.67503888 |
59 | ITK | 0.67499222 |
60 | CAMK1D | 0.65869140 |
61 | SYK | 0.64678274 |
62 | PDPK1 | 0.64186466 |
63 | RPS6KC1 | 0.63817189 |
64 | RPS6KL1 | 0.63817189 |
65 | EPHA2 | 0.63583932 |
66 | PAK4 | 0.63370133 |
67 | MAPK12 | 0.63216849 |
68 | CDK7 | 0.63121929 |
69 | CAMKK1 | 0.62868660 |
70 | RPS6KA2 | 0.60309033 |
71 | RIPK1 | 0.59646196 |
72 | TESK2 | 0.59626660 |
73 | ARAF | 0.58326750 |
74 | RPS6KB2 | 0.57289943 |
75 | GRK6 | 0.56395592 |
76 | PDK1 | 0.56348487 |
77 | STK10 | 0.55554734 |
78 | FES | 0.53685125 |
79 | NEK9 | 0.53614573 |
80 | MAPK7 | 0.52636018 |
81 | MAP3K7 | 0.52195685 |
82 | MARK3 | 0.50677611 |
83 | MAP2K2 | 0.50642595 |
84 | LCK | 0.50548284 |
85 | LYN | 0.47202820 |
86 | MST1R | 0.47149497 |
87 | KSR2 | 0.46692786 |
88 | TYRO3 | 0.46619730 |
89 | BMX | 0.46524459 |
90 | MATK | 0.45687998 |
91 | PRKD3 | 0.44150174 |
92 | CDK6 | 0.43692187 |
93 | FGR | 0.43199316 |
94 | RPS6KA6 | 0.42410935 |
95 | MELK | 0.41666077 |
96 | IRAK1 | 0.37340184 |
97 | RPS6KA1 | 0.36840534 |
98 | MAPKAPK2 | 0.36000050 |
99 | RET | 0.34708218 |
100 | PRKCH | 0.34576627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.62190364 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.43289092 |
3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.22898417 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22593012 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.00297480 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94596473 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87313665 |
8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.83123612 |
9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.83018730 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81340109 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79037911 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76474796 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69270134 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63327414 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59898555 |
16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.59557319 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54849179 |
18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54121760 |
19 | Influenza A_Homo sapiens_hsa05164 | 1.52538094 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52423810 |
21 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.45955842 |
22 | Hepatitis B_Homo sapiens_hsa05161 | 1.45088246 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44777727 |
24 | Measles_Homo sapiens_hsa05162 | 1.42626148 |
25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41633491 |
26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.40098870 |
27 | Asthma_Homo sapiens_hsa05310 | 1.38678832 |
28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36561943 |
29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35380776 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33508555 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27468777 |
32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27467127 |
33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26771955 |
34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.26770665 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25821341 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24696387 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23345127 |
38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23297124 |
39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.23062184 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.22137937 |
41 | Bladder cancer_Homo sapiens_hsa05219 | 1.18017191 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.16275202 |
43 | Tuberculosis_Homo sapiens_hsa05152 | 1.15915428 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.10513861 |
45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09873289 |
46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08709135 |
47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04778583 |
48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04038308 |
49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00343890 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99284743 |
51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98821162 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97000378 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93211344 |
54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91343621 |
55 | Prostate cancer_Homo sapiens_hsa05215 | 0.89228395 |
56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87528650 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.87099056 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86284096 |
59 | Lysosome_Homo sapiens_hsa04142 | 0.85619258 |
60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83464592 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83137896 |
62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82223400 |
63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81425846 |
64 | Alcoholism_Homo sapiens_hsa05034 | 0.80820662 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80587600 |
66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78665485 |
67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77872046 |
68 | Prion diseases_Homo sapiens_hsa05020 | 0.77744936 |
69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77480649 |
70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76522797 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76263094 |
72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75510385 |
73 | Glioma_Homo sapiens_hsa05214 | 0.72756393 |
74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71095666 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70595679 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.68990803 |
77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68692611 |
78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67229230 |
79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66808914 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66808524 |
81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66379080 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64411641 |
83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64164799 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63535801 |
85 | Lysine degradation_Homo sapiens_hsa00310 | 0.60432068 |
86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60378611 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59850108 |
88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59537382 |
89 | Malaria_Homo sapiens_hsa05144 | 0.58611809 |
90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57893079 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54980507 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.53367210 |
93 | Spliceosome_Homo sapiens_hsa03040 | 0.52987085 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.51703107 |
95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51425185 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.51317998 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50918727 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50646346 |
99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50645932 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50199892 |